Stock Market News
ImmuPharma raises £10m following investor demans
Specialist drug discovery and development company ImmuPharma announced on Wednesday that, in response to institutional demand, it has completed a fundraise totalling £10m before expenses via a placing of 6,944,445 new ordinary shares at a price of 144p per share, with new and existing investors.
The AIM-traded firm said it would apply the additional funds to support future investment in its P140 peptide platform.
It also said the proceeds of the placing would provide it with additional working capital.
"With our recent key milestone being announced confirming the completion of our Phase III trial of Lupuzor, the company is now at an exciting and pivotal phase of its development," said ImmuPharma chairman Tim McCarthy.
"We were approached by new institutions, introduced by Turner Pope Investments, keen to support ImmuPharma over the next period of growth.
"We are therefore delighted to be able to announce this Placing that includes both new and existing institutions to support our continued development."
McCarthy said the proceeds of the placing would allow the company to make investment into potential indications emanating from its P140 platform, in addition to lupus.
The placing also further strengthened the balance sheet, and enhances ImmuPharma's position in ongoing and future negotiations with potential partners for Lupuzor, he added.
"We look forward to providing our shareholders with further updates regarding the Lupuzor Phase III trial with key data still on track to be announced before the end of Q1 2018."
The AIM-traded firm said it would apply the additional funds to support future investment in its P140 peptide platform.
It also said the proceeds of the placing would provide it with additional working capital.
"With our recent key milestone being announced confirming the completion of our Phase III trial of Lupuzor, the company is now at an exciting and pivotal phase of its development," said ImmuPharma chairman Tim McCarthy.
"We were approached by new institutions, introduced by Turner Pope Investments, keen to support ImmuPharma over the next period of growth.
"We are therefore delighted to be able to announce this Placing that includes both new and existing institutions to support our continued development."
McCarthy said the proceeds of the placing would allow the company to make investment into potential indications emanating from its P140 platform, in addition to lupus.
The placing also further strengthened the balance sheet, and enhances ImmuPharma's position in ongoing and future negotiations with potential partners for Lupuzor, he added.
"We look forward to providing our shareholders with further updates regarding the Lupuzor Phase III trial with key data still on track to be announced before the end of Q1 2018."
Related share prices |
---|
Immupharma (IMM) share price |
Stock News headlines are gathered from financial news sources around the web. Views and opinions on each item are from their respective authors and website. They are not opinions of LiveCharts.co.uk
Get a free widget for your website with our latest headlines.
You can now add our live prices and new headlines to your website.The news widget features quotes for Oil prices, spot Gold price and Indices plus a choice of news channel for healines.
Top Shares pages
- Share price quotes
- Share charts
- Share watch list
- Company Results Calendar
- Top Large UK Shares
- UK Market Sectors
- Stock market news
- Company news
- Share tips
- A-Z company search
More share features
POPULAR Share Prices
- Royal Mail share price
- Lloyds share price
- HSBC share price
- Barclays share price
- Prudential share price
- Santander share price
- NEXT share price
- Diageo share price
- BP share price
- Vodafone share price
- British Airways
- Centrica share price
- Tesco share price
- Taylor Wimpey Share Price
- National Grid
- GKP Share Price
- Marks and Spencer
- Rolls Royce
- Rio Tinto
- THG Share Price
- Aviva Share Price
- Boil Share price
- Easyjet Share Price
- Genedrive Share Price
- SSE Share Price
- IAG Share Price
- Boohoo share price
- HE1 share price
- AVCT share price
- BOOM share price